# CRYL1

## Overview
CRYL1, or crystallin lambda 1, is a gene that encodes a protein belonging to the lambda-crystallin family, which is primarily recognized for its structural role in the eye lens. However, the CRYL1 protein is also expressed in non-ocular tissues, particularly in the liver and kidney, where it is implicated in metabolic processes. The protein is characterized by two HCDH (3-hydroxyacyl-CoA dehydrogenase) domains, suggesting a potential enzymatic function related to fatty acid metabolism, although direct enzyme activity has not been confirmed (Chen2003Human). CRYL1 is highly homologous to rabbit λ-crystallin and contains an NAD-binding site, indicating a possible role in metabolic pathways involving NAD (Chen2003Human). The gene's expression pattern and sequence conservation across species suggest a significant role in maintaining metabolic balance, particularly in the liver and kidney (Chen2003Human). Additionally, CRYL1 has been associated with stress protection and cellular signaling pathways, potentially interacting with proteins involved in neurodegenerative processes (Tindale2017Lipid; Gusareva2014Genomewide).

## Structure
The CRYL1 protein, encoded by the human CRYL1 gene, is highly homologous to rabbit λ-crystallin and contains two HCDH (3-hydroxyacyl-CoA dehydrogenase) domains, which are putative NAD- or FAD-binding domains (Chen2003Human). The primary structure of CRYL1 consists of 319 amino acids (Chen2003Human). The protein features an NAD-binding site located in the N-terminal region (positions 3 to 190) and a C-terminal domain (positions 192 to 283), consistent across homologs in other species (Chen2003Human).

The CRYL1 protein is expressed in various human tissues, with particularly high levels in the liver and kidney, suggesting a conserved function across species (Chen2003Human). The protein's quaternary structure is suggested to be dimeric, similar to its rabbit counterpart, which forms a dimeric structure with a molecular weight of 70 kDa (Ishikura2005Structural). The CRYL1 protein is related to L-3-hydroxyacyl-CoA dehydrogenase, an enzyme involved in fatty acid metabolism, indicating potential enzymatic functions despite the lack of detected enzyme activity (Chen2003Human). The expression pattern and sequence homology suggest a role in metabolism, particularly in the liver and kidney (Chen2003Human).

## Function
The CRYL1 gene encodes a protein that is part of the lambda-crystallin family, which is known for its structural role in the eye lens. However, CRYL1 is also expressed in non-ocular tissues, particularly in the liver and kidney, where it is overexpressed compared to other tissues (Chen2003Human). The protein encoded by CRYL1 contains two HCDH domains, suggesting a potential enzymatic function similar to 3-hydroxyacyl-CoA dehydrogenase, an enzyme involved in fatty acid metabolism (Chen2003Human). This enzyme is critical in the fatty acid β-oxidation pathway, which is essential for energy production, indicating that CRYL1 may have a metabolic role in these tissues (Chen2003Human).

CRYL1 is highly homologous with rabbit l-crystallin and contains an NAD-binding site, which suggests a role in metabolic processes involving NAD (Chen2003Human). The protein is predicted to be 319 amino acids long and shares significant sequence identity with crystallin proteins from other species, suggesting a conserved function (Chen2003Human). The high expression of CRYL1 in the liver and kidney may be due to their roles in metabolism, particularly in maintaining metabolic balance and processing fatty acids (Chen2003Human).

## Clinical Significance
The CRYL1 gene, also known as crystallin lambda 1, has been implicated in various clinical conditions due to alterations in its expression levels. In hepatocellular carcinoma (HCC), CRYL1 is significantly downregulated in 58% of cases, suggesting a potential role in liver cancer carcinogenesis (Chen2003Human). This downregulation is associated with certain clinical features, such as age and hepatitis B surface antigen status, although it does not correlate with other factors like tumor size or alpha-fetoprotein levels (Chen2003Human).

CRYL1 is also involved in metabolic processes, and its expression is negatively correlated with tumor stage and nodal metastasis in HCC, indicating that higher levels of CRYL1 might improve prognosis (Bi2021Identification). The gene's expression is lower in HCC tissues compared to normal liver tissues, highlighting its potential as a prognostic biomarker and therapeutic target (Bi2021Identification).

In zebrafish, CRYL1 is a cadmium-responsive gene, with its expression being upregulated upon cadmium exposure, suggesting a role in stress response mechanisms (Scudiero2017Retinoblastoma). However, specific diseases or conditions in humans directly linked to CRYL1 mutations are not detailed in the provided context.

## Interactions
CRYL1, a member of the crystallin family, is suggested to have potential interactions with other proteins, particularly in the context of stress protection and cellular signaling pathways. A network analysis identified CRYL1 as part of a gene network associated with healthy aging and longevity, highlighting its connection to APOE by one node. This suggests a possible interaction between CRYL1 and the APOE4 allele, particularly with CRYL1 GG and GT genotypes (Tindale2017Lipid).

CRYL1 is hypothesized to function as a stress-protective heat-shock protein, potentially interacting with KHDRBS2 within the TOR pathway. This interaction may influence β-amyloid plaques and Alzheimer's disease-like deficits, indicating a role in neurodegenerative processes (Tindale2017Lipid; Gusareva2014Genomewide). The interaction between CRYL1 and KHDRBS2 is further supported by a genome-wide association study, which identified SNPs in the intronic regions of these genes, suggesting a functional link along the cellular stress-TOR-heat-shock protein axis (Gusareva2014Genomewide).

While these studies suggest potential interactions, further research is needed to confirm the specific physical interactions of CRYL1 with other proteins or nucleic acids.


## References


[1. (Chen2003Human) Jian Chen, Long Yu, Dan Li, Qin Gao, Jishi Wang, Xinghua Huang, Gang Bi, Hai Wu, and Shouyuan Zhao. Human cryl1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58. Gene, 302(1–2):103–113, January 2003. URL: http://dx.doi.org/10.1016/s0378-1119(02)01095-8, doi:10.1016/s0378-1119(02)01095-8. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(02)01095-8)

[2. (Gusareva2014Genomewide) Elena S. Gusareva, Minerva M. Carrasquillo, Céline Bellenguez, Elise Cuyvers, Samuel Colon, Neill R. Graff-Radford, Ronald C. Petersen, Dennis W. Dickson, Jestinah M. Mahachie John, Kyrylo Bessonov, Christine Van Broeckhoven, Denise Harold, Julie Williams, Philippe Amouyel, Kristel Sleegers, Nilüfer Ertekin-Taner, Jean-Charles Lambert, and Kristel Van Steen. Genome-wide association interaction analysis for alzheimer’s disease. Neurobiology of Aging, 35(11):2436–2443, November 2014. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2014.05.014, doi:10.1016/j.neurobiolaging.2014.05.014. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2014.05.014)

[3. (Ishikura2005Structural) S. Ishikura. Structural and functional characterization of rabbit and human l-gulonate 3-dehydrogenase. Journal of Biochemistry, 137(3):303–314, March 2005. URL: http://dx.doi.org/10.1093/JB/MVI033, doi:10.1093/jb/mvi033. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/JB/MVI033)

[4. (Bi2021Identification) Yiming Bi, Bei Yin, and Guanjie Fan. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis. Hereditas, April 2021. URL: http://dx.doi.org/10.1186/s41065-021-00177-x, doi:10.1186/s41065-021-00177-x. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s41065-021-00177-x)

[5. (Tindale2017Lipid) Lauren C. Tindale, Stephen Leach, John J. Spinelli, and Angela R. Brooks-Wilson. Lipid and alzheimer’s disease genes associated with healthy aging and longevity in healthy oldest-old. Oncotarget, 8(13):20612–20621, February 2017. URL: http://dx.doi.org/10.18632/oncotarget.15296, doi:10.18632/oncotarget.15296. This article has 29 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.15296)

[6. (Scudiero2017Retinoblastoma) Rosaria Scudiero, Maria Grazia Esposito, Palma Simoniello, and Chiara Maria Motta. Retinoblastoma binding protein 6 and crystallin lambda 1 are cadmium-responsive genes in zebrafish embryos and adults retinae. Comptes Rendus. Biologies, 340(4):197–203, April 2017. URL: http://dx.doi.org/10.1016/j.crvi.2017.03.004, doi:10.1016/j.crvi.2017.03.004. This article has 3 citations.](https://doi.org/10.1016/j.crvi.2017.03.004)